|
|
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial
Vincent Ribrag
,
Serge Koscielny
,
Jacques Bosq
,
Thibaut Leguay
,
Olivier Casasnovas
et al.
Journal articles
inserm-01419476v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group
Thorsten Braun
,
Sophie Cereja
,
Sylvie Chevret
,
Emmanuel Raffoux
,
Marie Beaumont
et al.
Journal articles
hal-01237097v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
Raouf Ben Abdelali
,
Vahid Asnafi
,
Thibaut Leguay
,
Nicolas Boissel
,
Agnès Buzyn
et al.
Journal articles
hal-00777203v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study
Mathilde Hunault-Berger
,
Thibaut Leguay
,
Françoise Huguet
,
Stéphane Leprêtre
,
Eric Deconinck
et al.
Journal articles
hal-01237093v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group
Lionel Adès
,
Xavier Thomas
,
Agnes Cuerci-Bres
,
Raffoux Emmanuel
,
Olivier Spertini
et al.
Blood, 2015, 126 (23), pp.451
Journal articles
hal-01300812v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study
Stéphane Leprêtre
,
Aurore Touzart
,
Thomas Vermeulin
,
Jean-Michel Picquenot
,
Aline Schmidt-Tanguy
et al.
Journal articles
inserm-01411210v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A Phase 2 Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
Hagop M. Kantarjian
,
Bruno Lioure
,
Ehab Atallah
,
Thibaut Leguay
,
Kevin Kelly
et al.
Journal articles
hal-01259441v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.
Mathilde Hunault-Berger
,
Thibaut Leguay
,
Xavier Thomas
,
Ollivier Legrand
,
Françoise Huguet
et al.
Journal articles
hal-00821138v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience
Marie-Anne Couturier
,
Françoise Huguet
,
Patrice Chevallier
,
Felipe Suarez
,
Xavier Thomas
et al.
Journal articles
hal-01231425v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a group for research in adult acute lymphoblastic leukemia study
Jonathan Bond
,
Tony Marchand
,
Aurore Touzart
,
Agata Cieslak
,
Amélie Trinquand
et al.
Journal articles
hal-01290420v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|